GenScript will launch services with GANP technology for World Wide market excluding Japan
GenScript Corporation signed a worldwide (excluding Japan) non-exclusive license agreement with TransGenic Inc. through which GenScript Corporation is authorized to use GANP mice from TransGenic Inc. to produce high-affinity antibodies to scientists.
GANP (Germinal Center Associated Nuclear Protein) is a protein discovered by Dr. Nobuo Sakaguchi at Kumamoto University to be over-expressed in B-cells centered in embryo. Research suggested that GANP is important in the reconstruction of antibody genes. Transgenic mice which express high level of GANP can be used to produce ...